- Forums
- ASX - By Stock
- UNS
- Amgen officially buys the rights for some of Unilife’s drug delivery devices for $75M
Amgen officially buys the rights for some of Unilife’s drug delivery devices for $75M, page-3
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online